期刊文献+

食管癌内科治疗及综合治疗进展 被引量:25

Progress of Medical and Combined Treatment for Esophageal Carcinoma
下载PDF
导出
摘要 食管癌的综合治疗已日益受到临床的重视,放疗、化疗、手术三者的结合是食管癌综合治疗的趋势,合理而有效的综合治疗,已取得较单一方法更为满意的疗效,提高了患者的长期生存率。新的化疗药物的应用、对新辅助化疗的认识、和对辅助性化疗的再认识是食管癌内科治疗领域近年来发展的亮点。本文综述了近年来相关重要文献和临床试验,对食管癌的内科治疗和综合治疗进展作一介绍和述评,尤其是在疗效、生存率和不良反应等方面。 The combined treatment for esophageal carcinoma evoked increasing attention in clinic. The combination of radiotherapy, chemotherapy and operation is the tendency of combined treatment for esophageal carcinoma. The rational and efficient combined treatment has made more satisfied curative effect than single treatment, which improved the patients' long-term survival rate. Using new chemotherapeutic agents, exploring neoadjuvant chemotherapy, and renewing knowledge of adjuvant chemotherapy are important developments on medical treatment for esophageal carcinoma. This review discussed the progress of medical and combined treatment for esophageal carcinoma from the aspects of curative effect, survival rate, adverse events, and so on.
出处 《癌症》 SCIE CAS CSCD 北大核心 2006年第4期509-515,共7页 Chinese Journal of Cancer
关键词 食管肿瘤 化学疗法 新辅助治疗 综合治疗 Esophageal neoplasm Chemotherapy Neoadjuvant chemotherapy Combined treatment
  • 相关文献

参考文献60

  • 1中国肿瘤防治研究办公室.中国试点市、县恶性肿瘤的发病与死亡[M].北京:中国医药科技出版社,2002:28-34.
  • 2Kelsen D P,Ilson D H.Chemotherapy and combined-modality therapy for esophageal cancer[J].Chest,1995,107(6 Suppl):224-232.
  • 3Schmoll H J,Kohne C H,Papageorglou,et al.Single agent lobaplatin is active in patients with esophageal carcinoma:a phase 2evaluation(Abstract 483)[J].Proc Am Soc Clin Oncol,1995,14:201.
  • 4李醒亚,申淑景,王瑞林,樊青霞.紫杉醇治疗食管癌疗效分析[J].癌症,1999,18(3):327-329. 被引量:29
  • 5Conroy T,Etienne P L.Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus:response,toxicity,quality of life and survival[J].Ann Oncol,2002,13(5):721-729.
  • 6Vignoud J,Visset J,Paineau J,et al.Preoperative chemotherapy in squamous cell carcinoma of the esophagus:clinical and pathological analysis,48cases (Abstract)[J].Ann Oncol,1990,1 (Suppl):45.
  • 7Richel D J,Vervenne W L.Systemic treatment of oesophageal cancer[J].Eur Gastroenterol Hepatol,2004,16(3):249-254.
  • 8El-Rayes B F,Shields A,Zalupski M,et al.A phase Ⅱ study of carboplatin and paclitaxel in esophageal cancer[J].Ann Oncol,2004,15(6):960-965.
  • 9Polee M B,Eskens F A,van der Burg M E,et al.Phase Ⅱ study of biweekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer[J].BrCancer,2002,86 (5):669-673.
  • 10Lordick F,von Schilling C,Bernhard H,et al.Phase Ⅱ trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer[J].Br J Cancer,2003,89(4):630-633.

二级参考文献53

  • 1张志贤,冯勤富,谷铣之,殷蔚伯,杨宗贻,苗延浚,汪楣,黄国俊,张大为,张汝刚,汪良骏.食管癌术前放疗的评价——附1012例分析[J].中华放射肿瘤学杂志,1992,0(3):26-28. 被引量:16
  • 2张亚历 姜泊 等.程序化细胞死亡常用研究方法.分子生物学常用实验方法(第一版)[M].北京:人民军医出版社,1996.176.
  • 3黄国俊 张大为 等.食管术前放射治疗和外科综合治疗113例总结[J].中华医学杂志,1962,2:770-774.
  • 4黄国俊 谷铣之 等.食管中段癌单纯手术与术前放射治疗综合治疗480例报告[J].中华肿瘤杂志,1980,2:15-18.
  • 5汪楣 谷铣之 等.术前放射治疗和外科手术综合治疗食管癌的临床研究[J].中国放射肿瘤学,1988,2:31-33.
  • 6汪良骏 黄国俊 等.食管中段单纯手术与术前放射治疗综合治疗的研究-前瞻性随机分组360例[J].中国放射肿瘤学,1990,4:81-83.
  • 7张毓德 杜喜群 等.食管中段癌的术前60钴放射与外科综合治疗(附200例对比分析)[J].胸心血管外科杂志,1988,4:31-33.
  • 8Hertel L W,Boder GB, Kroin JS,et al. Evaluation of the antitumor activity of gemcitabine (2, 2-deoxycytidine). Cancer Res, 1990,50 (14): 4417~4422.
  • 9Moorsel CJAV, Veerman G, Bergman AM, et al. Combination chemotherapy studies with gemcitabine. Semin Oncol, 1997, 24(2): 17~23 (Suppl 17).
  • 10中国肿瘤防治研究办公室卫生部统计信息中心.中国试点市、县恶性肿瘤的发病与死亡[M].北京:中国医药科技出版社,2002.28-34.

共引文献190

同被引文献251

引证文献25

二级引证文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部